MGON Megola Inc.

MEGOLA, INC / ACORDY SA (OTCBB: MGON) PROVIDES SHAREHOLDER UPDATE WITH EXPANSION OF CANNABIS PRODUCTS TO US MARKETS

MEGOLA, INC / ACORDY SA (OTCBB: MGON) PROVIDES SHAREHOLDER UPDATE WITH EXPANSION OF CANNABIS PRODUCTS TO US MARKETS

Houston, Texas, Oct. 25, 2018 (GLOBE NEWSWIRE) -- Publicly-held Megola, Inc. (OTC Pink: MGON) is pleased to announce expansion of its products and sales distributions into the United States and Canadian cannabis markets. Acordy President Francisco Baez states: “Megola plans on introducing medical marijuana products into the U.S. developed by it’s affiliated company Acordy S.A. based in Malaga, Spain. Megola is also in advanced negotiations with a U.S. developer of new, innovative and therapeutic medical marijuana products”. Eric Ottens, CEO of Megola states, “We are leveraging the already existing product set of Acordy  to quickly launch, produce and sell into the US and Canadian cannabis markets.”   

Francisco Baez also stated, “We have secured legal counsel and we are taking the necessary steps to bring all OTC filings current. While we are currently trading on the Pinksheets, we plan on moving up to OTCQB or OTCQX within the next 6-12 months..”

The company also wishes to notify all shareholders and persons of interest that Megola, Inc. will be making announcements and updates via social media media. Updates can be found at on newly created new social media channels on Twitter and a Facebook Business Page .

Management also wants to notify all shareholders and persons of interest to visit for updates and notifications of the company’s original programs and directives.

About Acordy SA.

Acordy S.A. is currently a privately owned Spanish company that was formed in 2014. Acordy has been primarily involved in the production and distribution of food items from Spain with a concentration in olive oils and wines from the Iberian Peninsula. Acordy is also involved with commercial horse breeding. The company is currently planning to become involved in the production and distribution of medical marijuana products and already has the necessary infrastructure in place to commence commercializing CBD products in the next three months.

###

Sections of this press release contain forward looking statements that reflect management’s best judgement based on factors currently known but involve significant risks and uncertainties. Actual results could differ materially from those anticipated in these forward looking statements as a result of a number of factors that will be included in the forthcoming financial statements. Forward looking information provided pursuant to the safe harbor established by recent securities legislation should be evaluated in the context of these factors.  

SOURCE Megola, Inc.

 

RELATED LINKS







For further information, contact:
Eric Ottens
 
EN
25/10/2018

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Megola Inc.

 PRESS RELEASE

Megola, Inc. Announces Receivership Closed and Next Steps for CBD Dist...

Megola, Inc. Announces Receivership Closed and Next Steps for CBD Distribution Houston, Texas, Feb. 27, 2019 (GLOBE NEWSWIRE) -- Megola, Inc. (OTC: MGON), Megola Corp. CEO Eric Ottens, is pleased to announce that the status of the receivership has been resolved with the Courts and has been posted with the Nevada Secretary of State. Ottens stated: “This is a major accomplishment. We could not update the company information with OTC until this matter was resolved and finalized. We will now move forward with updating the registration filing with OTC and from there we can begin implementing ...

 PRESS RELEASE

Megola, Inc. Announces Test Marketing of CBD Products - OG Kush Produc...

Megola, Inc. Announces Test Marketing of CBD Products - OG Kush Product Lines Houston, Texas, Dec. 13, 2018 (GLOBE NEWSWIRE) -- Megola, Inc. (OTC: MGON), Megola Corp. CEO Eric Ottens, says that Acordy President, Francis Baez, has disclosed that the initial test marketing of their OG Kush products have been well received by customers in Europe. The Cannaviar, the banana OG Kush and the OG Kush oil seems to be particularly favorites. In the U.S. the OG Kush strain of medical marijuana is renowned for its medicinal qualities and it is easily one of the most popular strains sold by dis...

 PRESS RELEASE

Megola, Inc. Announces it is in the Process of Making its Filings Curr...

Megola, Inc. Announces it is in the Process of Making its Filings Current with the OTC Houston, Texas, Dec. 04, 2018 (GLOBE NEWSWIRE) -- Megola, Inc. (OTC: MGON), has announced it is complying with the filing regulations of the OTC Markets and will be current in its submissions within the next two weeks. Megola’s CEO, Eric Ottens, also took the added measure of visiting Spain to verify status of the Cannabis harvest, olive oil packaging and distribution facilities for purposes of proper disclosure. MGON plans on having its financial statements audited in the near future in order to qual...

 PRESS RELEASE

MEGOLA, INC / ACORDY SA (OTCBB: MGON) PROVIDES SHAREHOLDER UPDATES OF ...

MEGOLA, INC / ACORDY SA (OTCBB: MGON) PROVIDES SHAREHOLDER UPDATES OF FINANCIAL STATUS OF COMPANY AND FUTURE DIRECTION Houston, Texas, Nov. 01, 2018 (GLOBE NEWSWIRE) -- Publicly-held Megola, Inc. (OTC Pink: MGON) is pleased to announce current status of revenues and future direction of sales distributions into the United States and Canadian CBD (Cannabidiol) markets. Acordy President Francisco Baez states: “For 2018, the Company is rapidly approaching 2 million euros ($2.4 million US Dollars) in revenues. This reflects an increase of over 300% compared with the same nine month period of ...

 PRESS RELEASE

MEGOLA, INC / ACORDY SA (OTCBB: MGON) PROVIDES SHAREHOLDER UPDATE WIT...

MEGOLA, INC / ACORDY SA (OTCBB: MGON) PROVIDES SHAREHOLDER UPDATE WITH EXPANSION OF CANNABIS PRODUCTS TO US MARKETS Houston, Texas, Oct. 25, 2018 (GLOBE NEWSWIRE) -- Publicly-held Megola, Inc. (OTC Pink: MGON) is pleased to announce expansion of its products and sales distributions into the United States and Canadian cannabis markets. Acordy President Francisco Baez states: “Megola plans on introducing medical marijuana products into the U.S. developed by it’s affiliated company Acordy S.A. based in Malaga, Spain. Megola is also in advanced negotiations with a U.S. developer of new, inn...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch